 Effects atenolol nifedipine combination ambulant myocardial ischemia effects atenolol mg/day nifedipine times combination ambulant myocardial ischemia double-blind placebo-controlled crossover trial Eighteen men symptomatic coronary artery disease exercise-induced ischemia minimal symptoms underwent treatment periods weeks duration placebo atenolol nifedipine ischemia monotherapy combination therapy drugs ambulatory electrocardiographic monitoring ischemic parameters end period nifedipine atenolol monotherapy number ischemic episodes average duration episode placebo placebo nifedipine total duration ischemia effect atenolol ischemia duration borderline significance differences reduction ischemic parameters atenolol nifedipine difference significant patients ischemia monotherapy combination therapy duration patients placebo conclusion monotherapy nifedipine atenolol effective ambulant ischemia Combination therapy additional benefit continued ischemia